1.Milder Form of Urea Cycle Defect Revisited: Report and Review of Hyperornithinaemia-Hyperammonaemia-Homocitrullinuria (HHH) Syndrome Diagnosed in a Teenage Girl Presenting with Recurrent Encephalopathy.
Syeda Kashfi QADRI ; Teck Wah TING ; James Sc LIM ; Saumya Shekhar JAMUAR
Annals of the Academy of Medicine, Singapore 2016;45(12):563-566
Amino Acid Transport Systems, Basic
;
genetics
;
Brain Diseases
;
diagnosis
;
etiology
;
Child
;
DNA Mutational Analysis
;
Diet, Protein-Restricted
;
Female
;
Humans
;
Hyperammonemia
;
complications
;
diagnosis
;
diet therapy
;
genetics
;
Ornithine
;
deficiency
;
genetics
;
Recurrence
;
Severity of Illness Index
;
Urea Cycle Disorders, Inborn
;
complications
;
diagnosis
;
diet therapy
;
genetics
2.Therapeutics in paediatric genetic diseases: Current and future landscape.
Ai Ling KOH ; Saumya Shekhar JAMUAR
Singapore medical journal 2023;64(1):7-16
There are more than 7,000 paediatric genetic diseases (PGDs) but less than 5% have treatment options. Treatment strategies targeting different levels of the biological process of the disease have led to optimal health outcomes in a subset of patients with PGDs, where treatment is available. In the past 3 decades, there has been rapid advancement in the development of novel therapies, including gene therapy, for many PGDs. The therapeutic success of treatment relies heavily on knowledge of the genetic basis and the disease mechanism. Specifically, gene therapy has been shown to be effective in various clinical trials, and indeed, these trials have led to regulatory approvals, paving the way for gene therapies for other types of PGDs. In this review, we provide an overview of the treatment strategies and focus on some of the recent advancements in therapeutics for PGDs.
Child
;
Humans
;
Genetic Diseases, Inborn/therapy*
;
Genetic Therapy